Tonix Pharmaceuticals Holding Corp.

TNXP

—

Advanced chart & tools →

Tonix Pharmaceuticals Holding Corp.TNXP

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-14.57

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$13.11M

Net income

$-124.02M

Net margin

-946.2%

Gross margin

—

Dividends & financials

Tonix Pharmaceuticals Holding Corp. (TNXP) reported revenue of $13.11M and net income of $-124.02M, or $-14.57 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.